Design Therapeutics (DSGN) Other Non-Current Assets (2020 - 2025)

Design Therapeutics has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $427000.0 for Q1 2025.

• Other Non-Current Assets for Q1 2025 came in at $427000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2025 was $427000.0 (changed 0.0% YoY), and the FY2024 annual result was $427000.0, down 0.7% from the prior year.
• Other Non-Current Assets came in at $427000.0 for Q1 2025 at Design Therapeutics, roughly flat from $427000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $474000.0 in Q2 2022 to a low of $427000.0 in Q1 2024.
• The 4-year median for Other Non-Current Assets is $433500.0 (2023), against an average of $441583.3.
• Across the five-year window, Other Non-Current Assets fell 6.33% in 2023 and changed 0.0% in 2025, its largest moves.
• Design Therapeutics' Other Non-Current Assets stood at $459000.0 in 2022, then retreated by 6.32% to $430000.0 in 2023, then slipped by 0.7% to $427000.0 in 2024, then changed by 0.0% to $427000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $427000.0 (Q1 2025), $427000.0 (Q4 2024), and $427000.0 (Q3 2024), per Business Quant data.